Loading clinical trials...
Loading clinical trials...
A developed multimodal intervention targeting late effects in survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) will be evaluated in a two-arm randomized controlled trial wit...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rigshospitalet, Denmark
Collaborators
NCT06548958 · Malignant Hematological Diseases
NCT06113601 · Hematological Diseases, Critical Illness
NCT05002582 · Hematological Diseases, Carbapenem-resistant Enterobacteriaceae, and more
NCT01959100 · Malignant Hematological Diseases
NCT01344681 · Febrile Neutropenia, Hematological Diseases
Rigshospitalet
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions